Carregant...
A132 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY
BACKGROUND: Anti-TNF dose is frequently increased or dosing interval shortened in IBD subjects with persistent gastrointestinal symptoms. Evidence supporting dose augmentation is of low quality and the practice imparts a significant additional cost of care. Persons with symptoms ascribed to IBD may...
Guardat en:
| Publicat a: | J Can Assoc Gastroenterol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512673/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.131 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|